South Bend Tribune 1 month ago

FDA questions Zimmer study :Concerned if payments swayed implant trial results.

Associated Press Writer WASHINGTON — Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial... Full Article at South Bend Tribune

Related Topics:

  1. US Food and Drug Administration
  2. Food and Drug Administration
  3. NYSE

Related Articles

  1. Indianapolis Star logo
    FDA questions role of payments in Zimmer study
    1 month ago

    WASHINGTON -- Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data. Full Article at Indianapolis Star

  2. FDA staff note financial ties in Zimmer spine study
    1 month ago

    In documents released on Monday, Food and Drug Administration reviewers said there was “a trend which suggests the possibility of bias from compensation” when payments or stock holdings were analyzed for any influence in the study of a proposed new use... Full Article at Times Live South Africa

  3. FDA questions role of payments in Zimmer study
    1 month ago

    WASHINGTON (AP) - Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data. Full Article at WCAX

Related Quotes

There are no results for this module. Edi the module to change the search term used to query related quotes.

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta(TM) surgical lead for neurostimulation therapy.
  2. WASHINGTON - JUNE 12: University of Florida's Emerging Pathogens Institute Director Glenn Morris testifies before the House Subcommittee on Oversight and Investigations June 12, 2008 in Washington, DC.
  3. WASHINGTON - APRIL 22: Commissioner of the Food and Drug Administration Andrew von Eschenbach testifies during a hearing before the Subcommittee on Oversight and Investigations of the House Energy & Commerce Committee April 22, 2008 on Capitol Hill in Washington, DC.
  4. St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta(TM) surgical lead for neurostimulation therapy.
  5. SEOUL, SOUTH KOREA - OCTOBER 27: Medical workers of the Korea University Hospital wait for vaccination of H1N1 swine flu vaccine at Korea University Hospital on October 27, 2009 in Seoul, South Korea.
  6. WASHINGTON - SEPTEMBER 29: Senate Judiciary Committee's Crime and Drugs Subcommittee Chairman Arlen Specter (D-PA) delivers an opening statement during a hearing on 'Body Building Products and Hidden Steroids: Enforcement Barriers' on Capitol Hill September 29, 2009 in Washington, DC.

Cast of Characters

  1. US Food and Drug Administration US Food and Drug Administration
  2. Food and Drug Administration Food and Drug Administration
  3. NYSE NYSE